NCT04447521 Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium Status COMPLETED Phase N/A
NCT04446039 Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea Status COMPLETED Phase N/A
NCT04440176 A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules Status COMPLETED Phase PHASE2
NCT04440163 MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age Status COMPLETED Phase PHASE3
NCT04435769 Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment Status COMPLETED Phase N/A
NCT04428502 Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA) Status COMPLETED Phase N/A
NCT04428424 Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients Status COMPLETED Phase N/A
NCT04428411 Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO). Status COMPLETED Phase N/A
NCT04427917 Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants Status COMPLETED Phase PHASE1
NCT04424316 A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. Status COMPLETED Phase PHASE3
NCT04424303 Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase N/A
NCT04413617 TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE Status COMPLETED Phase PHASE2
NCT04412252 Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy Status WITHDRAWN Phase PHASE2
NCT04410809 Study Of Safety, Tolerability And Pharmacokinetics Of Subcutaneous Doses Of TA-46 Status COMPLETED Phase PHASE1
NCT04408794 Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine Status COMPLETED Phase PHASE2/PHASE3
NCT04403776 PK and Bioavailability Comparison of Tofacitinib Between a Modified Release and The Immediate Release Formulation Status COMPLETED Phase PHASE1
NCT04399538 Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis Status COMPLETED Phase PHASE2